Propranolol Shows Efficacy in Reducing the Risk of ROP Progression

• Posted on: Dec 27 2023
• By: Saratoga Opthalmology
• Leave a response

While there are many published studies regarding the use of oral propranolol for prevention of retinopathy of prematurity (ROP), there is no general consensus on the advantages and risks of this therapy.
Source: AAO

Posted in: Uncategorized